B.C. to limit sales of diabetes drug Ozempic to non-Canadians as demand soars amid weight-loss claims

The province of British Columbia says it’s planning to restrict how much Ozempic can be sold to non-Canadian citizens as American demand for the diabetes drug surges, driven by celebrities and online influencers claiming it can help with weight loss.

Health Minister Adrian Dix on Tuesday said a provincial analysis found 15 per cent of Ozempic sales in the first two months of the year went to U.S. residents — a worryingly high rate, he said, considering the average for other drugs sold to Americans was less than half a per cent.

“This is concerning and, in my view, it has to stop … the purpose of protecting Ozempic access in British Columbia is not to turn around and

→ Continue reading at CBC News

Related articles


Share article

Latest articles